The intratumor heterogeneity of prostate epithelial cells in multi-focal PC has been previously established and variable expression levels of various epithelial biomarkers including CD49f and TROP2 were found to define distinct epithelial subsets within tumor foci [12, 14–17]. This evidence concerns the gene TACSTD2 and neoplasm.